261 related articles for article (PubMed ID: 26783066)
1. Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells.
Fang Y; Zhang Q; Wang X; Yang X; Wang X; Huang Z; Jiao Y; Wang J
Int J Oncol; 2016 Mar; 48(3):1016-28. PubMed ID: 26783066
[TBL] [Abstract][Full Text] [Related]
2. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
Ouyang G; Yao L; Ruan K; Song G; Mao Y; Bao S
Cell Biol Int; 2009 Dec; 33(12):1237-44. PubMed ID: 19732843
[TBL] [Abstract][Full Text] [Related]
3. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
[TBL] [Abstract][Full Text] [Related]
4. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
[TBL] [Abstract][Full Text] [Related]
5. Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells.
Raman V; Fuentes Lorenzo JL; Stashenko EE; Levy M; Levy MM; Camarillo IG
Int J Oncol; 2017 Dec; 51(6):1801-1808. PubMed ID: 29075784
[TBL] [Abstract][Full Text] [Related]
6. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
7. Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways.
Wu YM; Chen ZJ; Jiang GM; Zhang KS; Liu Q; Liang SW; Zhou Y; Huang HB; Du J; Wang HS
Oncotarget; 2016 Mar; 7(11):12568-81. PubMed ID: 26871469
[TBL] [Abstract][Full Text] [Related]
8. Selenocystine-induced cell apoptosis and S-phase arrest inhibit human triple-negative breast cancer cell proliferation.
Long M; Wu J; Hao J; Liu W; Tang Y; Li X; Su H; Qiu W
In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1077-84. PubMed ID: 26194802
[TBL] [Abstract][Full Text] [Related]
9. Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells.
Gangapuram M; Jean R; Mazzio E; Badisa R; Eyunni S; Goodman CB; Redda KK; Soliman KF
Anticancer Res; 2016 Oct; 36(10):5043-5052. PubMed ID: 27798863
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
11. EGFR and MEK Blockade in Triple Negative Breast Cancer Cells.
Maiello MR; D'Alessio A; Bevilacqua S; Gallo M; Normanno N; De Luca A
J Cell Biochem; 2015 Dec; 116(12):2778-85. PubMed ID: 25959272
[TBL] [Abstract][Full Text] [Related]
12. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the molecular mechanism underlying anticancer activity of coumestrol in triple-negative breast cancer cells.
Zafar A; Singh S; Satija YK; Saluja D; Naseem I
Toxicol In Vitro; 2018 Feb; 46():19-28. PubMed ID: 28986287
[TBL] [Abstract][Full Text] [Related]
14. A novel chalcone-based molecule, BDP inhibits MDA‑MB‑231 triple-negative breast cancer cell growth by suppressing Hsp90 function.
Oh YJ; Seo YH
Oncol Rep; 2017 Oct; 38(4):2343-2350. PubMed ID: 28849241
[TBL] [Abstract][Full Text] [Related]
15. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation.
Zou M; Li Y; Xia S; Chu Q; Xiao X; Qiu H; Chen Y; Zheng Z; Liu F; Zhuang L; Yu S
Cell Physiol Biochem; 2017; 44(2):778-791. PubMed ID: 29169152
[TBL] [Abstract][Full Text] [Related]
17. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
18. Genistein enhances the radiosensitivity of breast cancer cells via G₂/M cell cycle arrest and apoptosis.
Liu X; Sun C; Jin X; Li P; Ye F; Zhao T; Gong L; Li Q
Molecules; 2013 Oct; 18(11):13200-17. PubMed ID: 24284485
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel inhibitor of triple-negative breast cancer cell growth by screening of a small-molecule library.
Fujita T; Mizukami T; Okawara T; Inoue K; Fujimori M
Breast Cancer; 2014 Nov; 21(6):738-47. PubMed ID: 23456737
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Soliman KFA
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]